Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01130675 · ClinicalTrials.gov registry record · Phase 3
Does Coffee Consumption Prevent or Shorten Postoperative Ileus After Colon Resection?
A Phase 3 study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- Phase 3
- Development phase
- 44
- Enrollment target
NCT01130675 is a Phase 3 study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 44 participants.
The verdict
NCT01130675, a Phase 3 study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 44 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if consuming an 8 ounce cup of coffee with breakfast and lunch is effective in preventing or reducing postoperative ileus.
Interventions
- OTHER caffeinated coffee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2010-04 |
| Est. Completion | 2011-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01130675
The ClinicalTrials.gov registry entry for NCT01130675 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which caffeinated coffee is the first listed.
NCT01130675 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01130675 about?
NCT01130675 is a clinical study titled "Does Coffee Consumption Prevent or Shorten Postoperative Ileus After Colon Resection?". The purpose of this study is to determine if consuming an 8 ounce cup of coffee with breakfast and lunch is effective in preventing or reducing postoperative ileus.
What is the current status of trial NCT01130675?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 44 participants. The study started on 2010-04. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01130675?
The interventions under investigation include: caffeinated coffee (OTHER).
Who is sponsoring clinical trial NCT01130675?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.